Herpes zoster vaccine live: A 10 year review of post-marketing safety experience.

•After 10 years of post-marketing use, safety of zoster vaccine live remains favorable.•93% of reports of adverse experiences were non-serious.•Injection-site reactions were the most commonly reported adverse experience.•Vaccine-strain varicella-zoster virus was identified by PCR in 14 specimens.•Disseminated herpes zoster was reported very rarely.